There were 1,631 press releases posted in the last 24 hours and 438,603 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image